Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts

Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated August 4, 2023, please note that the audio recording of the earnings call on the unaudited financial results for the first quarter ended June 30, 2023, held on August 14, 2023, at 8.30 AM (IST), has been uploaded on our website on the following web-link: https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/audio-or-video-recordings/

pdf

Aurobindo Pharma Ltd.

01 Jun 2023

1050.30

0.61%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please refer to our letter dated May 19, 2023, wherein we intimated about the schedule of Investors/ Analysts call on May 29, 2023. We are attaching herewith the Transcript of the said analyst / investor call on the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2023, and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/conference-call-transcripts/

pdf

Aurobindo Pharma Ltd.

29 May 2023

1050.30

0.61%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated May 19, 2023, please note that the audio recording of the earnings call on the audited financial results for the fourth quarter and year ended March 31, 2023, held on May 29, 2023, at 8.30 AM (IST), has been uploaded on our website on the following web-link: https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/audio-or-video-recordings/

pdf

Aurobindo Pharma Ltd.

17 Feb 2023

1050.30

0.61%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Q3 FY23 earnings call

pdf

Aurobindo Pharma Ltd.

10 Feb 2023, 04:08PM

1050.30

0.61%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated February 3, 2023, please note that the audio recording of the earnings call on the unaudited financial results for the third quarter and nine months period ended December 31, 2022, held on February 10, 2023, at 8.30 AM (IST), has been uploaded on our website on the following web-link: https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/audio-or-video-recordings/

pdf

Aurobindo Pharma Ltd.

18 Nov 2022

1050.30

0.61%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Sub: Transcript of Q2FY23 earnings call. Please refer to our letter dated November 8, 2022 wherein we intimated about the schedule of Investors/ Analysts call on November 14, 2022. We are attaching herewith the Transcript of the said analyst / investor call on the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2022 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/conference-call-transcripts/ Please take the information on record.

pdf

Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts